2013
DOI: 10.5812/ijb.10717
|View full text |Cite
|
Sign up to set email alerts
|

A Simple and Rapid Method for the Detection of HIV-1/HCV in Co-Infected Patients

Abstract: Background: Due to some limitations of serological methods in diagnosis of patients infected with HIV-1 (human immunodeficiency virus) and HCV (hepatitis C virus), it is profoundly important to use molecular methods for the detecting of these infectious agents. However, the most significant problems are the exorbitant cost of these methods and the need of a thermocycler which is an expensive instrument. Objectives: The current research recruits a multiplex nucleic acid sequence base amplification (NASBA) in or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…Higher ratio is in favor of higher risk of malignancy. The ratio more than 0.75 is considered as significant and is consistent with prostate cancer ( Figure 2 ) ( 31 , 32 ).…”
Section: Resultsmentioning
confidence: 93%
“…Higher ratio is in favor of higher risk of malignancy. The ratio more than 0.75 is considered as significant and is consistent with prostate cancer ( Figure 2 ) ( 31 , 32 ).…”
Section: Resultsmentioning
confidence: 93%
“…A multiplex NASBA assay was used for simultaneous detection of HIV-1 and HCV in plasma samples. The LoD of the assay for both HIV-1 and HCV was determined to be 1000 copies/ml and no cross-reactions with other selected viruses [ 45 ]. Swenson and his colleagues [ 75 ] used real-time TMA for the detection of HSV-1 and HSV-2 in lesion swab specimens with overall sensitivities of 98.2% and 99.4%, respectively, and specificity of 97.8% and 94.5%, respectively, compared to culture.…”
Section: Molecular Diagnostic Techniques Of Medical Virusesmentioning
confidence: 99%
“…Commercial NASBA assays are clinically used for the detection of RSV [38], HIV-1 [39], CMV [40] and human papillomavirus (HPV) [41]. A multiplex NASBA assay for HIV-1 and HCV has been developed and demonstrated an analytical sensitivity of 1000 copies/mL, 93.3% clinical sensitivity, and 100% specificity [42].…”
Section: Nucleic Acid Sequence Based Amplification (Nasba)mentioning
confidence: 99%